Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension

Cardiovascular Research

Volumn 96, Issue 3, 2012, Pages 552-560

  Xu, Haibo ^a   Oliveira Sales, Elizabeth B ^b   McBride, Fiona ^a   Liu, Beihui ^a   Hewinson, James ^a   Toward, Marie ^a   Hendy, Emma B ^a   Graham, Delyth ^c   Dominiczak, Anna F ^c   Giannotta, Monica ^d   Waki, Hidefumi ^e   Ascione, Raimondo ^f   Paton, Julian F R ^a   Kasparov, Sergey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adhesion molecules; Angiotensin; Hypertension; JAM A; Vasculature

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; HYDRALAZINE; JUNCTIONAL ADHESION MOLECULE A; LOSARTAN; MESSENGER RNA; MORPHOLINO OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BRAIN MICROCIRCULATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE COURSE; DOWN REGULATION; HEART; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY; LEUKOCYTE; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SAPHENOUS VEIN; SPLEEN; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE; UPREGULATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; BLOOD VESSELS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; HYDRALAZINE; HYPERTENSION; HYPERTENSION, RENOVASCULAR; LOSARTAN; MALE; MORPHOLINOS; PREHYPERTENSION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TIME FACTORS; UP-REGULATION; VASODILATOR AGENTS;

EID: 84868088725     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs273     Document Type: Article

References (26)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003;289:2560-2572. (Pubitemid 37430158)
2. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C et al. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 2010;107:263-270.
3. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol 2010;10:203-207.
4. Zubcevic J, Waki H, Raizada MK, Paton JF. Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 2011;57:1026-1033.
5. Mart̀in-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998;142:117-127. (Pubitemid 28341144)
6. Kornecki E, Walkowiak B, Naik UP, Ehrlich YH. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 1990;265:10042- 10048.
7. Naik UP, Ehrlich YH, Kornecki E. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor. Biochem J 1995;310:155-162.
8. Mandell KJ, Parkos CA. The JAM family of proteins. Adv Drug Deliv Rev 2005;57:857-867. (Pubitemid 40488107)
9. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003;24:327-334.
10. Severson EA, Parkos CA. Mechanisms of outside-in signaling at the tight junction by junctional adhesion molecule A. Ann N Y Acad Sci 2009;1165:10-18.
11. Waki H, Liu B, Miyake M, Katahira K, Murphy D, Kasparov S et al. Junctional adhesion molecule-1 is up regulated in the spontaneously hypertensive rat: evidence for a pro-hypertensive role within the brainstem. Hypertension 2007;49:1321-1327. (Pubitemid 46809375)
12. Ong KL, Leung RY, Wong LY, Cherny SS, Sham PC, Lam TH et al. Association of F11 receptor gene polymorphisms with central obesity and blood pressure. J Intern Med 2008;263:322-332. (Pubitemid 351207343)
13. Ong KL, Leung RY, Babinska A, Salifu MO, Ehrlich YH, Kornecki E et al. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens 2009;22:500-505.
14. Nabika T, Cui Z, Masuda J. The stroke-prone spontaneously hypertensive rat: how good is it as a model for cerebrovascular diseases? Cell Mol Neurobiol 2004;24:639-646. (Pubitemid 39062427)
15. Oliveira-Sales EB, Colombari DS, Davisson RL, Kasparov S, Hirata AE, Campos RR et al. Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 2010;56:290-296.
16. Cera MR, Del PA, Vecchi A, Corada M, Mart̀in-Padura I, Motoike T et al. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 2004;114:729-738. (Pubitemid 39578763)
17. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000;113:2363-2374. (Pubitemid 30599341)
18. Liang TW, DeMarco RA, Mrsny RJ, Gurney A, Gray A, Hooley J et al. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol 2000;279:C1733-C1743.
19. Cera MR, Fabbri M, Molendini C, Corada M, Orsenigo F, Rehberg M et al. JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci 2009;122:268-277.
20. Babinska A, Kedees MH, Athar H, Ahmed T, Batuman O, Ehrlich YH et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost 2002;88:843-850. (Pubitemid 35350778)
21. Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C. Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev 2009; 17:216-221.
22. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008;29:367-374.
23. Luft FC. Angiotensin, inflammation, hypertension, and cardiovascular disease. Curr Hypertens Rep 2001;3:61-67.
24. Liu HQ, Wei XB, Sun R, Cai YW, Lou HY, Wang JW et al. Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells. Life Sci 2006;78:1293-1298. (Pubitemid 43199949)
25. Sobocki T, Sobocka MB, Babinska A, Ehrlich YH, Banerjee P, Kornecki E. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junc-tional adhesion molecule-1/JAM-A. Gene 2006;366:128-144. (Pubitemid 43199602)
26. Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, Nourshargh S. Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood 2009;113:6246-6257.